Cited by 255Clinical Laboratory Practices and Quality ControlT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research

Considerations for the control of background fluorescence in clinical flow cytometry

Open access
Hulspas, Ruud, O'Gorman, Maurice R.G., Wood, Brent L., Gratama, Jan W., Sutherland, D. Robert·2009·Cytometry Part B: Clinical Cytometry

Abstract

Accurate measurement of antigen‐positive cells by flow cytometry can be hampered by background fluorescence of antigen‐negative cells and other particles (e.g., debris). This article focuses on three major causes of background (autofluorescence, spectral overlap, and undesirable antibody binding) by reviewing individual aspects of flow cytometric measurements that contribute to these causes. The appropriate use of controls facilitates a thorough understanding of these contributing factors as well as the development of robust cell labeling protocols intended for routine flow cytometric analysis. We present a set of recommendations that enables the user to develop an optimized cell labeling protocol that minimizes background and maximizes the ability to reliably distinguish between a positive and a negative population of cells. These recommendations are also intended to augment existing guidelines designed to aid in the formulation of a consensus regarding the utility of flow cytometry for the analysis of clinical samples. © 2009 Clinical Cytometry Society

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cyto.b.20485

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An isotype control antibody is not useful for determining or excluding non-specific binding in flow cytometry.

    “Although some continue to use an isotype control Ab to determine/exclude non-specific binding, the isotype control is not useful in this context [2].”

    From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [2]

    The 'Understand and Minimize Undesirable Antibody Binding' section says isotype controls are not recommended for determining nonspecific binding in quantitative cell-counting assays. But the 'ISOTYPE CONTROLS' section says a perfectly matched control can help determine undesirable binding and that isotype controls may have utility in some qualitative assays. The claim's unqualified statement that they are not useful is therefore broader than the paper's conclusion. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 58 · Cited by 255

Research works printed but not linked: 10

  1. Stelzer GT, Marti G, Hurley A, McCoy P, Lovett EJ, Schwartz A. U.S.- Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardiza- tion and validation of laboratory procedures. Cytometry 1997;30: 214-230.
  2. Gratama JW, Kraan J, Keeney M, Mandy F, Sutherland DR, Wood BL. Enumeration of Immunologically Defined Cell Populations by Flow Cytometry: Approved Guideline, 2nd ed (H42-A2, Vol. 27, No. 16). Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
  3. Baumgarth N, Bigos M. Optimization of emission optics. In: Darzyn- kiewicz Z, Roederer M, Tanke HJ, editors. Methods in Cell Biology, Vol. 75: Cytometry: New Developments, 4th ed. San Diego, CA: Academic Press; 2004. pp 3-22.
  4. Kantor AB, Roederer M. FACS analysis of leukocytes. In: Herzenberg LA, Weir DM, Herzenberg, LA, Blackwell C, editors. Handbook of Experimental Immunology, 5th ed. Cambridge, MA: Blackwell Scien- tific; 1996. Chapter 49.
  5. Roederer M, Kantor AB, Parks DR, Herzenberg LA. Cy7PE and Cy7APC: Bright new probes for immunofluorescence. Cytometry 1996;24:191-197.
  6. Stewart C, Stewart S. Cell preparation for the identification of leu- kocytes. In: Darzynkiewicz Z, Robinson J, Crissman H, editors. Methods in Cell Biology. New York: Academic Press; 1994. pp 39-60.
  7. Donnenberg AD, Donnenberg V. Understanding clinical flow cytom- etry. In: O'Gorman MRG, Donnenberg AD, editors. Handbook of Human Immunology, 2nd ed. Boca Raton, FL: CRC Press; 2008. pp 181-220.
  8. Langweiler M, Givan AL. Flow cytometry and quality control: An uneasy alliance. In: Stewart C, Nicholson J, editors. Immunopheno- typing. New York: Wiley-Liss; 2000. pp 23-49.
  9. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34þ cell counts based on the ISHAGE Guidelines. Cytometry (Commun Clin Cytometry) 1998;34:61-70.
  10. Mason D, Andre ´P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Hor ˇejs ˇi V, Jones Y, Meuer S, Morrissey JA, Schwartz-Albiez R, Shaw S, Simmons D, Turni L, Uguc- cioni M, van der Schoot E, Vivier E, Zola H, editors. Leucocyte Typ- ing VII. New York: Oxford University; 2002.

Authors
Hulspas, R., O'Gorman, M. R. G., Wood, B. L., Gratama, J. W., & Sutherland, D. R.
Affiliations
  • University of Washington (US)
  • Erasmus MC Cancer Institute (NL)
  • University Health Network (CA)
Corresponding author
Hulspas, Ruud
Venue
Cytometry Part B: Clinical Cytometry
Publisher
Wiley
Published
2009-07-02
Volume
76B
Issue
6
Pages
355-364
ISSN
  • 1552-4949 (ISSN-L)
  • 1552-4957
OpenAlex
W1997315475
Cited by
255
References
58
Citations by year
2026: 10 · 2025: 17 · 2024: 25 · 2023: 18 · 2022: 17 · 2021: 21 · 2020: 25 · 2019: 20 · 2018: 19 · 2017: 17 · 2016: 18 · 2015: 9 · 2014: 6 · 2013: 10 · 2012: 11
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Cytometry Part B Clinical Cytometry (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
Keywords
background fluorescence, autofluorescence, spectral overlap, antibody binding, clinical flow cytometry, debris
MeSH terms
Antibodies, Antibody Specificity, Flow Cytometry, Fluorescence, Fluorescent Dyes, Humans, Image Processing, Computer-Assisted, Quality Control, Staining and Labeling, Clinical Laboratory Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review